Do the results of your analysis make the case for existing Neuren shareholders to consider also taking a position in Acadia now, because (subject to the risks of the acquiror being a different entity), Acadia is the likely suitor, and NNZ-2591 would not be subject to anyone’s consent rights post acquisition, which would increase the value of NNZ-2591?
Ann: Q2 2023 quarterly activity and cash flow report, page-61
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.97 |
Change
0.070(0.35%) |
Mkt cap ! $2.552B | |||
| Open | High | Low | Value | Volume |
| $20.22 | $20.44 | $19.85 | $4.194M | 209.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2772 | $19.93 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.99 | 3310 | 1 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |